Preclinical Research
Answers to your questions on the development of biologics and biosimilars
 |
|
Renowned for our full-service offering, we often get asked — how does Altasciences manage the development process for biologics and biosimilars so seamlessly from the required preclinical studies to first-in-human trials? |
 |
When and How to Use Thromboelastography (TEG) in Preclinical Studies
|
|
Thromboelastography (TEG) is often used to measure clot strength, diagnose and quantify fibrinolysis, as well as help diagnose platelet dysfunction and hypercoagulability. TEG analysis is utilized in preclinical studies targeting bleeding disorders and platelet dysfunction, and can add valuable information in drug development focused on hematology and coagulation. Want to know more? Our scientific poster discusses the various benefits, challenges, and methods associated with the use of TEG in preclinical studies, including a case study. |
Use of Thromboelastography (TEG) in Preclinical Studies
Development of an IL-31-Induced Pruritus Model in Cynomolgus Monkeys
Effect of Housing on Stress-Related Parameters in NHPs
Detection of Peripheral Blood Foxp3+ Regulatory T Cell Population in a Preclinical Setting
Translatability of Non-Human Primate Cytokine Data to In-Life Parameters in Nonclinical
A Multi-Peptide Hybrid LC-MS/MS Assay for the Determination of CTI-1601 in Monkey Tissues Provides Insight into its Disposition and Processing
Assessing an animal welfare program
|
|
When choosing an outsourcing partner for your nonclinical studies, it is imperative to evaluate the strength of a contract research organization's animal welfare program. Since animal welfare is the cornerstone for achieving high quality scientific results, understanding the components of a successful program can guide you in your assessment. |